These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 1864844)
1. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex. Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844 [TBL] [Abstract][Full Text] [Related]
2. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist. Huang TF; Liu CZ; Ouyang CH; Teng CM Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom. Huang TF; Wang WJ; Teng CM; Ouyang C Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom. Huang TF; Sheu JR; Teng CM Thromb Haemost; 1991 Oct; 66(4):489-93. PubMed ID: 1665595 [TBL] [Abstract][Full Text] [Related]
5. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247 [TBL] [Abstract][Full Text] [Related]
6. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom. Huang TF; Sheu JR; Teng CM Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363 [TBL] [Abstract][Full Text] [Related]
7. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line. Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227 [TBL] [Abstract][Full Text] [Related]
8. Analysis of human platelet glycoprotein IIb-IIIa by fluorescein isothiocyanate-conjugated disintegrins with flow cytometry. Liu CZ; Wang YW; Shen MC; Huang TF Thromb Haemost; 1994 Dec; 72(6):919-25. PubMed ID: 7740464 [TBL] [Abstract][Full Text] [Related]
9. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa]. Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599 [TBL] [Abstract][Full Text] [Related]
10. A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist. Wang WJ; Huang TF Thromb Haemost; 2001 Oct; 86(4):1077-86. PubMed ID: 11686327 [TBL] [Abstract][Full Text] [Related]
12. Interaction of thrombin-activated platelets with extracellular matrices (fibronectin and vitronectin): comparison of the activity of Arg-Gly-Asp-containing venom peptides and monoclonal antibodies against glycoprotein IIb/IIIa complex. Sheu JB; Ko WC; Hung WC; Peng HC; Huang TF J Pharm Pharmacol; 1997 Jan; 49(1):78-84. PubMed ID: 9120775 [TBL] [Abstract][Full Text] [Related]
13. Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets. Huang TF; Holt JC; Kirby EP; Niewiarowski S Biochemistry; 1989 Jan; 28(2):661-6. PubMed ID: 2653425 [TBL] [Abstract][Full Text] [Related]
14. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor. Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911 [TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains. Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224 [TBL] [Abstract][Full Text] [Related]
17. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets. Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439 [TBL] [Abstract][Full Text] [Related]
18. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta. Sheu JR; Yen MH; Hung WC; Lee YM; Su CH; Huang TF Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3461-8. PubMed ID: 9437193 [TBL] [Abstract][Full Text] [Related]
19. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD. Rahman S; Lu X; Kakkar VV; Authi KS Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316 [TBL] [Abstract][Full Text] [Related]
20. Binding interactions of kistrin with platelet glycoprotein IIb-IIIa: analysis by site-directed mutagenesis. Dennis MS; Carter P; Lazarus RA Proteins; 1993 Mar; 15(3):312-21. PubMed ID: 8456099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]